{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:55:06Z","timestamp":1788188106231,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,6]]},"DOI":"10.7759\/cureus.17755","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T18:30:01Z","timestamp":1630953001000},"source":"Crossref","is-referenced-by-count":6,"title":["The Risk of Bleeding Complications in Intra-Articular Injections and Arthrocentesis in Patients on Novel Oral Anticoagulants: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Muhammad Yasir","family":"Tarar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Yin","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13299","article-title":"Trends in the prescription of novel oral anticoagulants in UK primary care","volume":"83","author":"Loo SY","year":"2017","unstructured":"Loo SY, Dell'Aniello S, Huiart L, Renoux C. Trends in the prescription of novel oral anticoagulants in UK primary care. Br J Clin Pharmacol. 2017, 83:2096-106. 10.1111\/bcp.13299","journal-title":"Br J Clin Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2019.03.013","article-title":"Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF","volume":"213","author":"Haas S","year":"2019","unstructured":"Haas S, Camm AJ, Bassand JP, et al.. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. Am Heart J. 2019, 213:35-46. 10.1016\/j.ahj.2019.03.013","journal-title":"Am Heart J"},{"key":"ref3","article-title":"Use of direct oral anticoagulants in daily practice","volume":"8","author":"Almarshad F","year":"2018","unstructured":"Almarshad F, Alaklabi A, Bakhsh E, Pathan A, Almegren M. Use of direct oral anticoagulants in daily practice. Am J Blood Res. 2018, 8:57-72.","journal-title":"Am J Blood Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S84210","article-title":"New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events","volume":"11","author":"Mekaj YH","year":"2015","unstructured":"Mekaj YH, Mekaj AY, Duci SB, Miftari EI. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag. 2015, 11:967-77. 10.2147\/TCRM.S84210","journal-title":"Ther Clin Risk Manag"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S191208","article-title":"Non-vitamin K oral anticoagulant use in the elderly: a prospective real-world study - data from the REGIstry of patients on Non-vitamin K oral Anticoagulants (REGINA)","volume":"15","author":"Monelli M","year":"2019","unstructured":"Monelli M, Molteni M, Cassetti G, et al.. Non-vitamin K oral anticoagulant use in the elderly: a prospective real-world study - data from the REGIstry of patients on Non-vitamin K oral Anticoagulants (REGINA). Vasc Health Risk Manag. 2019, 15:19-25. 10.2147\/VHRM.S191208","journal-title":"Vasc Health Risk Manag"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp20X711497","article-title":"The prevalence of musculoskeletal presentations in general practice: an epidemiological study","volume":"70","author":"Keavy R","year":"2020","unstructured":"Keavy R. The prevalence of musculoskeletal presentations in general practice: an epidemiological study. Br J Gen Pract. 2020, 70:10.3399\/bjgp20X711497","journal-title":"Br J Gen Pract"},{"key":"ref7","unstructured":"Anticoagulation therapy commissioning\r\nguide. (2013). Accessed. September 06, 2021: http:\/\/www.nwcscnsenate.nhs.uk\/files\/2314\/8665\/0540\/NICE_commissioning_guide_for_anticoagulation.pdf."},{"key":"ref8","unstructured":"Commissioning effective anticoagulation services. a resource pack for commissioners. (2016). Accessed: September 06, 2021: https:\/\/www.anticoagulationuk.org\/admin\/resources\/downloads\/commissioning-effective-anticoagulation-services-a-resour...."},{"key":"ref9","unstructured":"Anticoagulation - oral. (2021). Accessed. September 06, 2021: https:\/\/cks.nice.org.uk\/topics\/anticoagulation-oral\/."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.04.007","article-title":"Arthrocentesis and Joint Injection in Patients Receiving Direct Oral Anticoagulants","volume":"92","author":"Yui JC","year":"2017","unstructured":"Yui JC, Preskill C, Greenlund LS. Arthrocentesis and Joint Injection in Patients Receiving Direct Oral Anticoagulants. Mayo Clin Proc. 2017, 92:1223-6. 10.1016\/j.mayocp.2017.04.007","journal-title":"Mayo Clin Proc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MRR.0000000000000330","article-title":"Joint and soft-tissue injections in rehabilitation inpatients taking direct oral anticoagulants","volume":"42","author":"Nord HM","year":"2019","unstructured":"Nord HM, Journeay WS, Lipson DM. Joint and soft-tissue injections in rehabilitation inpatients taking direct oral anticoagulants. Int J Rehabil Res. 2019, 42:187-9. 10.1097\/MRR.0000000000000330","journal-title":"Int J Rehabil Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-eular.6640","article-title":"Is it safe to perform joint punctures in patients treated with dabigatran?","volume":"76","author":"Guillen-Astete C","year":"2017","unstructured":"Guillen-Astete C, Qui\u00f1ones-Torres J. Is it safe to perform joint punctures in patients treated with dabigatran?. Ann Rheum Dis. 2017, 76:996-7. 10.1136\/annrheumdis-2017-eular.6640","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13545","article-title":"Safety of arthrocentesis in patients receiving therapeutic anticoagulation with warfarin and direct oral anticoagulants - a retrospective study","volume":"22(Suppl 3)","author":"Mian M","year":"2019","unstructured":"Mian M, Shan S, Ramaraj P. Safety of arthrocentesis in patients receiving therapeutic anticoagulation with warfarin and direct oral anticoagulants - a retrospective study. Int J Rheum Dis. 2019, 22(Suppl 3):133-4. 10.1111\/1756-185X.13545","journal-title":"Int J Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim K","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003, 73:712-6. 10.1046\/j.1445-2197.2003.02748.x","journal-title":"ANZ J Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.642074","article-title":"A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement","volume":"114","author":"Eriksson BI","year":"2006","unstructured":"Eriksson BI, Borris LC, Dahl OE, et al.. A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement. Circulation. 2006, 114:2374-81. 10.1161\/CIRCULATIONAHA.106.642074","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2369","article-title":"Effectiveness and safety of direct oral anticoagulants versus warfarin in obese patients with acute venous thromboembolism","volume":"40","author":"Coons JC","year":"2020","unstructured":"Coons JC, Albert L, Bejjani A, Iasella CJ. Effectiveness and safety of direct oral anticoagulants versus warfarin in obese patients with acute venous thromboembolism. Pharmacotherapy. 2020, 40:204-10. 10.1002\/phar.2369","journal-title":"Pharmacotherapy"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.7150\/ijms.8916","article-title":"New oral anticoagulants vs vitamin K antagonists: benefits for health-related quality of life in patients with atrial fibrillation","volume":"11","author":"Alegret JM","year":"2014","unstructured":"Alegret JM, Vi\u00f1olas X, Arias MA. New oral anticoagulants vs vitamin K antagonists: benefits for health-related quality of life in patients with atrial fibrillation. Int J Med Sci. 2014, 11:680-684.","journal-title":"Int J Med Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2020.03.004","article-title":"Trends in incidence and prevalence of osteoarthritis in the United Kingdom: findings from the Clinical Practice Research Datalink (CPRD)","volume":"28","author":"Swain S","year":"2020","unstructured":"Swain S, Sarmanova A, Mallen C, Kuo CF, Coupland C, Doherty M, Zhang W. Trends in incidence and prevalence of osteoarthritis in the United Kingdom: findings from the Clinical Practice Research Datalink (CPRD). Osteoarthritis Cartilage. 2020, 28:792-801. 10.1016\/j.joca.2020.03.004","journal-title":"Osteoarthritis Cartilage"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2013.03.018","article-title":"The epidemiology and impact of pain in osteoarthritis","volume":"21","author":"Neogi T","year":"2013","unstructured":"Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage. 2013, 21:1145-53. 10.1016\/j.joca.2013.03.018","journal-title":"Osteoarthritis Cartilage"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11071","article-title":"Osteoarthritis in England: incidence trends from national health service hospital episode statistics","volume":"1","author":"Morgan OJ","year":"2019","unstructured":"Morgan OJ, Hillstrom HJ, Ellis SJ, et al.. Osteoarthritis in England: incidence trends from national health service hospital episode statistics. ACR Open Rheumatol. 2019, 1:493-8. 10.1002\/acr2.11071","journal-title":"ACR Open Rheumatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2011.599071","article-title":"Does ultrasound guidance improve the outcomes of arthrocentesis and corticosteroid injection of the knee?","volume":"41","author":"Sibbitt WL Jr","year":"2012","unstructured":"Sibbitt WL Jr, Kettwich LG, Band PA, Chavez-Chiang NR, DeLea SL, Haseler LJ, Bankhurst AD. Does ultrasound guidance improve the outcomes of arthrocentesis and corticosteroid injection of the knee?. Scand J Rheumatol. 2012, 41:66-72. 10.3109\/03009742.2011.599071","journal-title":"Scand J Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2013.07.372","article-title":"A comparison of ultrasound-guided to landmark-guided arthrocentesis of ankle, elbow, and wrist","volume":"62","author":"Gordon RD","year":"2013","unstructured":"Gordon RD, LaRavia L, Eric Z, Lyon M. A comparison of ultrasound-guided to landmark-guided arthrocentesis of ankle, elbow, and wrist. Ann Emerg Med. 2013, 62:S34. 10.1016\/j.annemergmed.2013.07.372","journal-title":"Ann Emerg Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.anclin.2010.08.013","article-title":"Anticoagulants: newer ones, mechanisms, and perioperative updates","volume":"28","author":"Gayle JA","year":"2010","unstructured":"Gayle JA, Kaye AD, Kaye AM, Shah R. Anticoagulants: newer ones, mechanisms, and perioperative updates. Anesthesiol Clin. 2010, 28:667-79. 10.1016\/j.anclin.2010.08.013","journal-title":"Anesthesiol Clin"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s40138-013-0014-6","article-title":"Anticoagulants: a review of the pharmacology, dosing, and complications","volume":"1","author":"Alquwaizani M","year":"2013","unstructured":"Alquwaizani M, Buckley L, Adams C, Fanikos J. Anticoagulants: a review of the pharmacology, dosing, and complications. Curr Emerg Hosp Med Rep. 2013, 1:83-97. 10.1007\/s40138-013-0014-6","journal-title":"Curr Emerg Hosp Med Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/dj4010005","article-title":"New direct oral anticoagulants (DOAC) and their use today","volume":"4","author":"Schwarb H","year":"2016","unstructured":"Schwarb H, Tsakiris DA. New direct oral anticoagulants (DOAC) and their use today. Dent J (Basel). 2016, 4:5. 10.3390\/dj4010005","journal-title":"Dent J (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-11-200312020-00007","article-title":"Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis","volume":"139","author":"Linkins LA","year":"2003","unstructured":"Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med. 2003, 139:893-900. 10.7326\/0003-4819-139-11-200312020-00007","journal-title":"Ann Intern Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3189","article-title":"Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study","volume":"353","author":"Larsen TB","year":"2016","unstructured":"Larsen TB, Skj\u00f8th F, Nielsen PB, Kj\u00e6ldgaard JN, Lip GY. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ. 2016, 353:i3189. 10.1136\/bmj.i3189","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvw031","article-title":"A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants","volume":"3","author":"Halvorsen S","year":"2017","unstructured":"Halvorsen S, Ghanima W, Fride Tvete I, Hoxmark C, Falck P, Solli O, Jonasson C. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants. Eur Heart J Cardiovasc Pharmacother. 2017, 3:28-36. 10.1093\/ehjcvp\/pvw031","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2505","article-title":"Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care","volume":"362","author":"Vinogradova Y","year":"2018","unstructured":"Vinogradova Y, Coupland C, Hill T, Hippisley-Cox J. Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care. BMJ. 2018, 362:k2505. 10.1136\/bmj.k2505","journal-title":"BMJ"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.07.013","article-title":"Direct comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in nonvalvular atrial fibrillation","volume":"150","author":"Noseworthy PA","year":"2016","unstructured":"Noseworthy PA, Yao X, Abraham NS, Sangaralingham LR, McBane RD, Shah ND. Direct comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in nonvalvular atrial fibrillation. Chest. 2016, 150:1302-12. 10.1016\/j.chest.2016.07.013","journal-title":"Chest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66939-the-risk-of-bleeding-complications-in-intra-articular-injections-and-arthrocentesis-in-patients-on-novel-oral-anticoagulants-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:51Z","timestamp":1707506931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66939-the-risk-of-bleeding-complications-in-intra-articular-injections-and-arthrocentesis-in-patients-on-novel-oral-anticoagulants-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.17755","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,6]]}}}